Migraine Medicines May Cause Potentially Deadly Brain Syndrome, Georgetown University Medical Center Study

Bloomberg -- Migraine headache medicines, including GlaxoSmithKline Plc’s Imitrex and Merck & Co.'s Maxalt, caused potentially fatal reactions in at least 11 people, according to today’s New England Journal of Medicine.

MORE ON THIS TOPIC